STAAR Surgical board reshuffles; Silverman rejoins, Weisner exits, Jiang takes APAC strategy role with $1.275M RSUs

STAAR SURGICAL CO

Louis Silverman reappointed to board effective April 24, 2025; board expands to 7 members.
Director Aimee Weisner will not stand for re-election at June 2025 annual meeting; board to shrink to 6.
Wei Jiang becomes Chief of APAC Strategy under consulting agreement through fiscal 2025, receiving RSUs valued at $1.275M.
CEO cites China distribution challenges, pre-tariff inventory at distributors, consignment agreements, and Swiss production ramp-up.
Company emphasizes cost control and improving profitability; earnings call expected in May 2025.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Aimee S. Weisner

director

STAA · STAAR SURGICAL CO

Filed: April 24, 2025, 7:59 PM ET

Ms. Weisner notified the Company that she has chosen not to stand for re-election when her term expires at the 2025 Annual Meeting

Appointed (interim)

Wei Jiang

Chief of APAC Strategy

STAA · STAAR SURGICAL CO

Effective: 2025-04-24
Filed: April 24, 2025, 7:59 PM ET

the Company entered into a consulting agreement with Mr. Jiang to serve as a special strategic advisor to the Company’s Asia Pacific business through the end of fiscal 2025, in the temporary role of Chief of APAC Strategy

Appointed

Louis E. Silverman

director

STAA · STAAR SURGICAL CO

Effective: 2025-04-24
Filed: April 24, 2025, 7:59 PM ET

the Board appointed Louis E. Silverman, who served on the Company’s Board from 2014-2022, as a director, effective April 24, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

Aimee S. Weisner departed as director at STAAR SURGICAL CO.

Action: not stand for re-election
Role: director

Exact text from the filing

Ms. Weisner notified the Company that she has chosen not to stand for re-election when her term expires at the 2025 Annual Meeting

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

Wei Jiang was appointed as Chief of APAC Strategy at STAAR SURGICAL CO.

Action: appointed
Role: Chief of APAC Strategy

Exact text from the filing

the Company entered into a consulting agreement with Mr. Jiang to serve as a special strategic advisor to the Company’s Asia Pacific business through the end of fiscal 2025, in the temporary role of Chief of APAC Strategy

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Louis E. Silverman was appointed as director at STAAR SURGICAL CO.

Action: appointed
Role: director

Exact text from the filing

the Board appointed Louis E. Silverman, who served on the Company’s Board from 2014-2022, as a director, effective April 24, 2025

View on SEC.gov

STAAR SURGICAL CO filing history →

Source: SEC EDGAR

accession 0000950170-25-058173

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.